- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Norwegian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
4
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
4 companies
BerGenBio
Market Cap: NOK 68.0m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway.
BGBIO
NOK 1.74
7D
11.2%
1Y
-89.3%
Thor Medical
Market Cap: NOK 756.2m
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 2.41
7D
9.6%
1Y
120.2%
PCI Biotech Holding
Market Cap: NOK 49.6m
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform.
PCIB
NOK 1.33
7D
2.3%
1Y
-25.3%
Nykode Therapeutics
Market Cap: NOK 724.9m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies.
NYKD
NOK 2.22
7D
9.4%
1Y
-83.4%